Irbesartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Irbesartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.
This report studies and analyses global lrbesartan status and future trends, helps the client to determine the lrbesartan market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for lrbesartan, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global lrbesartan market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global lrbesartan sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China lrbesartan sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global lrbesartan key consuming regions, consumption quantity, consumption value and demand structure
(5) Global lrbesartan key producing regions, capacity, production, and year over year growth
(6) lrbesartan industry chains, upstream, midstream and downstream
According to YH Research, the global market for lrbesartan should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China lrbesartan market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States lrbesartan market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Research Institute grew percent to account for percent of the total market sales, and Pharmaceutical grew percent.
Market segment by players, this report covers
Euroapi
Tenatra Chemie
Jai Radhe Sales
Dr. Reddy's Laboratories
Sanofi
Octavius Pharma
Teva
Piramal Group
Zydus Lifesciences
Macleods Pharmaceuticals
Cipla
Siegfried AG
Aurobindo
Alembic Pharmaceuticals
MSN Laboratories
Calyx Chemicals and Pharmaceuticals
Divis Laboratories
Mylan
Hetero Drugs
Apeloa Pharmaceutical
Market segment by Type, covers
Purity ≥ 98 %
Purity ≥ 99 %
Market segment by Application, can be divided into
Research Institute
Pharmaceutical
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe lrbesartan product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global lrbesartan market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China lrbesartan market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of lrbesartan, percent & CAGR, 2018-2029
Chapter 5: lrbesartan industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 lrbesartan Definition
1.2 Global lrbesartan Market Size and Forecast
1.2.1 By Consumption Value, Global lrbesartan Market Size,2018-2029
1.2.2 By Sales Quantity, Global lrbesartan Market Size,2018-2029
1.2.3 Global lrbesartan Average Selling Price (ASP),2018-2029
1.3 China lrbesartan Market Size and Forecast
1.3.1 By Consumption Value, China lrbesartan Market Size,2018-2029
1.3.2 By Sales Quantity, China lrbesartan Market Size,2018-2029
1.3.3 China lrbesartan Average Selling Price (ASP), 2018-2029
1.4 Share of China lrbesartan Market with Respect to the Global Market
1.4.1 By Consumption Value, China lrbesartan Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China lrbesartan Market Share in Global, 2018-2029
1.4.3 lrbesartan Market Size: China VS Global, 2018-2029
1.5 lrbesartan Market Dynamics
1.5.1 lrbesartan Market Drivers
1.5.2 lrbesartan Market Restraints
1.5.3 lrbesartan Industry Trends
1.5.4 lrbesartan Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of lrbesartan, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of lrbesartan, Global Market Share by Company, 2018-2023
2.3 lrbesartan Average Selling Price (ASP) by Company, 2018-2023
2.4 Global lrbesartan Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global lrbesartan Concentration Ratio
2.6 Global lrbesartan Mergers & Acquisitions, Expansion Plans
2.7 Global lrbesartan Manufacturers Product Type
2.8 Head Office and lrbesartan Production Site of Key Manufacturer
2.9 lrbesartan Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of lrbesartan, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of lrbesartan, China Market Share by Company, 2018-2023
3.3 China lrbesartan Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global lrbesartan Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global lrbesartan Capacity by Region
4.3 Global lrbesartan Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global lrbesartan Production by Region, 2018-2029
4.5 Global lrbesartan Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 lrbesartan Industry Chain
5.2 lrbesartan Upstream Analysis
5.2.1 lrbesartan Core Raw Materials
5.2.2 Main Manufacturers of lrbesartan Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 lrbesartan Production Mode
5.6 lrbesartan Procurement Model
5.7 lrbesartan Industry Sales Model and Sales Channels
5.7.1 lrbesartan Sales Model
5.7.2 lrbesartan Typical Distributors
6 Sights by Type
6.1 lrbesartan Classification
6.1.1 Purity ≥ 98 %
6.1.2 Purity ≥ 99 %
6.2 By Type, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global lrbesartan Consumption Value, 2018-2029
6.4 By Type, Global lrbesartan Sales Quantity, 2018-2029
6.5 By Type, Global lrbesartan Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 lrbesartan Segment by Application
7.1.1 Research Institute
7.1.2 Pharmaceutical
7.1.3 Others
7.2 By Application, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global lrbesartan Consumption Value, 2018-2029
7.4 By Application, Global lrbesartan Sales Quantity, 2018-2029
7.5 By Application, Global lrbesartan Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global lrbesartan Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global lrbesartan Consumption Value, 2018-2029
8.3 By Region, Global lrbesartan Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America lrbesartan & Forecasts, 2018-2029
8.4.2 By Country, North America lrbesartan Market Size Market Share
8.5 Europe
8.5.1 Europe lrbesartan Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe lrbesartan Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific lrbesartan Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific lrbesartan Market Size Market Share
8.7 South America
8.7.1 South America lrbesartan Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America lrbesartan Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global lrbesartan Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global lrbesartan Consumption Value, 2018-2029
9.3 By Country, Global lrbesartan Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. lrbesartan Market Size, 2018-2029
9.4.2 By Type, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe lrbesartan Market Size, 2018-2029
9.5.2 By Type, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China lrbesartan Market Size, 2018-2029
9.6.2 By Type, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan lrbesartan Market Size, 2018-2029
9.7.2 By Type, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea lrbesartan Market Size, 2018-2029
9.8.2 By Type, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia lrbesartan Market Size, 2018-2029
9.9.2 By Type, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India lrbesartan Market Size, 2018-2029
9.10.2 By Type, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa lrbesartan Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Euroapi
10.1.1 Euroapi Company Information, Head Office, Market Area, and Industry Position
10.1.2 Euroapi lrbesartan Models, Specifications, and Application
10.1.3 Euroapi lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Euroapi Company Profile and Main Business
10.1.5 Euroapi Recent Developments
10.2 Tenatra Chemie
10.2.1 Tenatra Chemie Company Information, Head Office, Market Area, and Industry Position
10.2.2 Tenatra Chemie lrbesartan Models, Specifications, and Application
10.2.3 Tenatra Chemie lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Tenatra Chemie Company Profile and Main Business
10.2.5 Tenatra Chemie Recent Developments
10.3 Jai Radhe Sales
10.3.1 Jai Radhe Sales Company Information, Head Office, Market Area, and Industry Position
10.3.2 Jai Radhe Sales lrbesartan Models, Specifications, and Application
10.3.3 Jai Radhe Sales lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Jai Radhe Sales Company Profile and Main Business
10.3.5 Jai Radhe Sales Recent Developments
10.4 Dr. Reddy's Laboratories
10.4.1 Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 Dr. Reddy's Laboratories lrbesartan Models, Specifications, and Application
10.4.3 Dr. Reddy's Laboratories lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Dr. Reddy's Laboratories Company Profile and Main Business
10.4.5 Dr. Reddy's Laboratories Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.5.2 Sanofi lrbesartan Models, Specifications, and Application
10.5.3 Sanofi lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Octavius Pharma
10.6.1 Octavius Pharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 Octavius Pharma lrbesartan Models, Specifications, and Application
10.6.3 Octavius Pharma lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Octavius Pharma Company Profile and Main Business
10.6.5 Octavius Pharma Recent Developments
10.7 Teva
10.7.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.7.2 Teva lrbesartan Models, Specifications, and Application
10.7.3 Teva lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Teva Company Profile and Main Business
10.7.5 Teva Recent Developments
10.8 Piramal Group
10.8.1 Piramal Group Company Information, Head Office, Market Area, and Industry Position
10.8.2 Piramal Group lrbesartan Models, Specifications, and Application
10.8.3 Piramal Group lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Piramal Group Company Profile and Main Business
10.8.5 Piramal Group Recent Developments
10.9 Zydus Lifesciences
10.9.1 Zydus Lifesciences Company Information, Head Office, Market Area, and Industry Position
10.9.2 Zydus Lifesciences lrbesartan Models, Specifications, and Application
10.9.3 Zydus Lifesciences lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Zydus Lifesciences Company Profile and Main Business
10.9.5 Zydus Lifesciences Recent Developments
10.10 Macleods Pharmaceuticals
10.10.1 Macleods Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.10.2 Macleods Pharmaceuticals lrbesartan Models, Specifications, and Application
10.10.3 Macleods Pharmaceuticals lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Macleods Pharmaceuticals Company Profile and Main Business
10.10.5 Macleods Pharmaceuticals Recent Developments
10.11 Cipla
10.11.1 Cipla Company Information, Head Office, Market Area, and Industry Position
10.11.2 Cipla lrbesartan Models, Specifications, and Application
10.11.3 Cipla lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Cipla Company Profile and Main Business
10.11.5 Cipla Recent Developments
10.12 Siegfried AG
10.12.1 Siegfried AG Company Information, Head Office, Market Area, and Industry Position
10.12.2 Siegfried AG lrbesartan Models, Specifications, and Application
10.12.3 Siegfried AG lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Siegfried AG Company Profile and Main Business
10.12.5 Siegfried AG Recent Developments
10.13 Aurobindo
10.13.1 Aurobindo Company Information, Head Office, Market Area, and Industry Position
10.13.2 Aurobindo lrbesartan Models, Specifications, and Application
10.13.3 Aurobindo lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Aurobindo Company Profile and Main Business
10.13.5 Aurobindo Recent Developments
10.14 Alembic Pharmaceuticals
10.14.1 Alembic Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.14.2 Alembic Pharmaceuticals lrbesartan Models, Specifications, and Application
10.14.3 Alembic Pharmaceuticals lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Alembic Pharmaceuticals Company Profile and Main Business
10.14.5 Alembic Pharmaceuticals Recent Developments
10.15 MSN Laboratories
10.15.1 MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
10.15.2 MSN Laboratories lrbesartan Models, Specifications, and Application
10.15.3 MSN Laboratories lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 MSN Laboratories Company Profile and Main Business
10.15.5 MSN Laboratories Recent Developments
10.16 Calyx Chemicals and Pharmaceuticals
10.16.1 Calyx Chemicals and Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.16.2 Calyx Chemicals and Pharmaceuticals lrbesartan Models, Specifications, and Application
10.16.3 Calyx Chemicals and Pharmaceuticals lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Calyx Chemicals and Pharmaceuticals Company Profile and Main Business
10.16.5 Calyx Chemicals and Pharmaceuticals Recent Developments
10.17 Divis Laboratories
10.17.1 Divis Laboratories Company Information, Head Office, Market Area, and Industry Position
10.17.2 Divis Laboratories lrbesartan Models, Specifications, and Application
10.17.3 Divis Laboratories lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Divis Laboratories Company Profile and Main Business
10.17.5 Divis Laboratories Recent Developments
10.18 Mylan
10.18.1 Mylan Company Information, Head Office, Market Area, and Industry Position
10.18.2 Mylan lrbesartan Models, Specifications, and Application
10.18.3 Mylan lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Mylan Company Profile and Main Business
10.18.5 Mylan Recent Developments
10.19 Hetero Drugs
10.19.1 Hetero Drugs Company Information, Head Office, Market Area, and Industry Position
10.19.2 Hetero Drugs lrbesartan Models, Specifications, and Application
10.19.3 Hetero Drugs lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Hetero Drugs Company Profile and Main Business
10.19.5 Hetero Drugs Recent Developments
10.20 Apeloa Pharmaceutical
10.20.1 Apeloa Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.20.2 Apeloa Pharmaceutical lrbesartan Models, Specifications, and Application
10.20.3 Apeloa Pharmaceutical lrbesartan Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Apeloa Pharmaceutical Company Profile and Main Business
10.20.5 Apeloa Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. lrbesartan Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. lrbesartan Market Restraints
Table 3. lrbesartan Market Trends
Table 4. lrbesartan Industry Policy
Table 5. Global lrbesartan Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global lrbesartan Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global lrbesartan Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global lrbesartan Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global lrbesartan Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global lrbesartan Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global lrbesartan Mergers & Acquisitions, Expansion Plans
Table 12. Global lrbesartan Manufacturers Product Type
Table 13. Head Office and lrbesartan Production Site of Key Manufacturer
Table 14. lrbesartan Capacity of Major Manufacturers and Future Plan
Table 15. China lrbesartan Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China lrbesartan Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China lrbesartan Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global lrbesartan Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global lrbesartan Production by Region, 2018-2023, (Tons)
Table 20. Global lrbesartan Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of lrbesartan Upstream (Raw Materials)
Table 22. Global lrbesartan Typical Customers
Table 23. lrbesartan Typical Distributors
Table 24. By Type, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global lrbesartan Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global lrbesartan Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global lrbesartan Consumption Value Market Share, 2018-2029
Table 32. By Country, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global lrbesartan Sales Quantity Market Share, 2018-2029
Table 34. Euroapi Company Information, Head Office, Market Area, and Industry Position
Table 35. Euroapi lrbesartan Models, Specifications, and Application
Table 36. Euroapi lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. Euroapi Company Profile and Main Business
Table 38. Euroapi Recent Developments
Table 39. Tenatra Chemie Company Information, Head Office, Market Area, and Industry Position
Table 40. Tenatra Chemie lrbesartan Models, Specifications, and Application
Table 41. Tenatra Chemie lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Tenatra Chemie Company Profile and Main Business
Table 43. Tenatra Chemie Recent Developments
Table 44. Jai Radhe Sales Company Information, Head Office, Market Area, and Industry Position
Table 45. Jai Radhe Sales lrbesartan Models, Specifications, and Application
Table 46. Jai Radhe Sales lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Jai Radhe Sales Company Profile and Main Business
Table 48. Jai Radhe Sales Recent Developments
Table 49. Dr. Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 50. Dr. Reddy's Laboratories lrbesartan Models, Specifications, and Application
Table 51. Dr. Reddy's Laboratories lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Dr. Reddy's Laboratories Company Profile and Main Business
Table 53. Dr. Reddy's Laboratories Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 55. Sanofi lrbesartan Models, Specifications, and Application
Table 56. Sanofi lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Octavius Pharma Company Information, Head Office, Market Area, and Industry Position
Table 60. Octavius Pharma lrbesartan Models, Specifications, and Application
Table 61. Octavius Pharma lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Octavius Pharma Company Profile and Main Business
Table 63. Octavius Pharma Recent Developments
Table 64. Teva Company Information, Head Office, Market Area, and Industry Position
Table 65. Teva lrbesartan Models, Specifications, and Application
Table 66. Teva lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Teva Company Profile and Main Business
Table 68. Teva Recent Developments
Table 69. Piramal Group Company Information, Head Office, Market Area, and Industry Position
Table 70. Piramal Group lrbesartan Models, Specifications, and Application
Table 71. Piramal Group lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Piramal Group Company Profile and Main Business
Table 73. Piramal Group Recent Developments
Table 74. Zydus Lifesciences Company Information, Head Office, Market Area, and Industry Position
Table 75. Zydus Lifesciences lrbesartan Models, Specifications, and Application
Table 76. Zydus Lifesciences lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Zydus Lifesciences Company Profile and Main Business
Table 78. Zydus Lifesciences Recent Developments
Table 79. Macleods Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 80. Macleods Pharmaceuticals lrbesartan Models, Specifications, and Application
Table 81. Macleods Pharmaceuticals lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Macleods Pharmaceuticals Company Profile and Main Business
Table 83. Macleods Pharmaceuticals Recent Developments
Table 84. Cipla Company Information, Head Office, Market Area, and Industry Position
Table 85. Cipla lrbesartan Models, Specifications, and Application
Table 86. Cipla lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Cipla Company Profile and Main Business
Table 88. Cipla Recent Developments
Table 89. Siegfried AG Company Information, Head Office, Market Area, and Industry Position
Table 90. Siegfried AG lrbesartan Models, Specifications, and Application
Table 91. Siegfried AG lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Siegfried AG Company Profile and Main Business
Table 93. Siegfried AG Recent Developments
Table 94. Aurobindo Company Information, Head Office, Market Area, and Industry Position
Table 95. Aurobindo lrbesartan Models, Specifications, and Application
Table 96. Aurobindo lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Aurobindo Company Profile and Main Business
Table 98. Aurobindo Recent Developments
Table 99. Alembic Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 100. Alembic Pharmaceuticals lrbesartan Models, Specifications, and Application
Table 101. Alembic Pharmaceuticals lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. Alembic Pharmaceuticals Company Profile and Main Business
Table 103. Alembic Pharmaceuticals Recent Developments
Table 104. MSN Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 105. MSN Laboratories lrbesartan Models, Specifications, and Application
Table 106. MSN Laboratories lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 107. MSN Laboratories Company Profile and Main Business
Table 108. MSN Laboratories Recent Developments
Table 109. Calyx Chemicals and Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 110. Calyx Chemicals and Pharmaceuticals lrbesartan Models, Specifications, and Application
Table 111. Calyx Chemicals and Pharmaceuticals lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 112. Calyx Chemicals and Pharmaceuticals Company Profile and Main Business
Table 113. Calyx Chemicals and Pharmaceuticals Recent Developments
Table 114. Divis Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 115. Divis Laboratories lrbesartan Models, Specifications, and Application
Table 116. Divis Laboratories lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 117. Divis Laboratories Company Profile and Main Business
Table 118. Divis Laboratories Recent Developments
Table 119. Mylan Company Information, Head Office, Market Area, and Industry Position
Table 120. Mylan lrbesartan Models, Specifications, and Application
Table 121. Mylan lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 122. Mylan Company Profile and Main Business
Table 123. Mylan Recent Developments
Table 124. Hetero Drugs Company Information, Head Office, Market Area, and Industry Position
Table 125. Hetero Drugs lrbesartan Models, Specifications, and Application
Table 126. Hetero Drugs lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 127. Hetero Drugs Company Profile and Main Business
Table 128. Hetero Drugs Recent Developments
Table 129. Apeloa Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 130. Apeloa Pharmaceutical lrbesartan Models, Specifications, and Application
Table 131. Apeloa Pharmaceutical lrbesartan Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 132. Apeloa Pharmaceutical Company Profile and Main Business
Table 133. Apeloa Pharmaceutical Recent Developments
List of Figures
Figure 1. lrbesartan Picture
Figure 2. Global lrbesartan Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global lrbesartan Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global lrbesartan Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China lrbesartan Consumption Value, (US$ million) & (2018-2029)
Figure 6. China lrbesartan Sales Quantity (Tons) & (2018-2029)
Figure 7. China lrbesartan Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China lrbesartan Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China lrbesartan Market Share of Global, 2018-2029
Figure 10. Global lrbesartan Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China lrbesartan Key Participants, Market Share, 2022
Figure 12. Global lrbesartan Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global lrbesartan Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global lrbesartan Production Market Share & Forecast by Region, 2018-2029
Figure 15. lrbesartan Industry Chain
Figure 16. lrbesartan Procurement Model
Figure 17. lrbesartan Sales Model
Figure 18. lrbesartan Sales Channels, Direct Sales, and Distribution
Figure 19. Purity ≥ 98 %
Figure 20. Purity ≥ 99 %
Figure 21. By Type, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global lrbesartan Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global lrbesartan Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global lrbesartan Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Research Institute
Figure 27. Pharmaceutical
Figure 28. Others
Figure 29. By Application, Global lrbesartan Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global lrbesartan Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 32. By Application, Global lrbesartan Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global lrbesartan Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 34. By Region, Global lrbesartan Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global lrbesartan Sales Quantity Market Share, 2018-2029
Figure 36. North America lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America lrbesartan Consumption Value Market Share, 2022
Figure 38. Europe lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe lrbesartan Consumption Value Market Share, 2022
Figure 40. Asia Pacific lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific lrbesartan Consumption Value Market Share, 2022
Figure 42. South America lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America lrbesartan Consumption Value Market Share, 2022
Figure 44. Middle East & Africa lrbesartan Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 46. By Type, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 49. By Type, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 51. China lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 52. By Type, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 55. By Type, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 58. By Type, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 61. By Type, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 63. India lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 64. By Type, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa lrbesartan Sales Quantity, 2018-2029, (Tons)
Figure 67. By Type, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa lrbesartan Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Reason to Buy